Advancing Translational Research
with Expert Precision

Alexis Hernandez

Alexis Hernandez combines a robust background in project management and process optimization with deep expertise in the pharmaceutical industry, making him a key asset to the Talon Biomarkers team as Operations Manager. With a Master’s degree in Business and Science, focusing on Drug Discovery and Development from Rutgers University, Alexis has consistently demonstrated his ability to navigate complex healthcare regulations and drive operational excellence. During his tenure at Pfizer, he was instrumental in developing vital assays for COVID-19 clinical programs, earning him the Vaccine R&D Team Award.

At Talon Biomarkers, Alexis has revitalized operational procedures, particularly in flow cytometry and cell culture practices, achieving significant compliance improvements and spearheading strategic enhancements that boosted the organization’s efficiency and client engagement. His innovative approach to business development, including refining pricing guidelines and contributing to impactful marketing initiatives, has markedly improved engagement metrics and fortified partnerships with key stakeholders.

With his comprehensive background and commitment to excellence, Alexis continues to enhance our operational capabilities and contribute to our mission of advancing health outcomes through innovative solutions.

Arielle Ginsberg

Arielle Ginsberg is a leader in the biotechnology and pharmaceutical sectors, currently serving as the Co-founder and Chief Commercial Officer at Talon Biomarkers. With a Master of Science in Bioinformatics from Brandeis University and a background that spans technical sales, marketing, and scientific research, Arielle is passionate about bridging the gap between cutting-edge scientific innovation and market needs.

Arielle excels in leveraging her comprehensive expertise to develop and implement innovative go-to-market strategies that drive the adoption of new technologies and implementation in existing research pipelines. Her strategic vision and meticulous execution have led to remarkable increases in customer engagement and satisfaction, making Talon Biomarkers a preferred partner in the industry. Under her leadership, the company has fostered strong cross-functional teams that execute tactical action plans, accelerating growth across key customer segments and distribution networks. This focused approach ensures that Talon Biomarkers not only meets but exceeds the expectations of their clients, providing advanced solutions that lead to better and more profound scientific outcomes.

Dr. Pratip Chattopadhyay

Dr. Pratip Chattopadhyay is an esteemed leader in the field of immunology and cytometry, known for his groundbreaking work in developing advanced cytometric assays and bioinformatics tools. As a post-doctoral fellow at the NIH, Dr. Chattopadhyay pioneered the use of CD154 expression to identify antigen-specific CD4+ T-cells, significantly advancing our understanding of immune responses. His work continued to revolutionize the field with the first 18-color flow cytometry experiments and the introduction of quantum dots and Brilliant dyes into flow cytometry, enhancing the multiplexing capabilities of this technology.

As the Founder and CEO of Talon Biomarkers, Dr. Chattopadhyay has positioned the company as a leader in biomarker discovery, providing cutting-edge immune monitoring services across various biomedical disciplines. His expertise in high-parameter cytometry technologies drives innovative research that aids in predicting patient outcomes, understanding disease pathogenesis, and designing effective drug therapies.

Dr. Chattopadhyay’s contributions to the scientific community are reflected in his roles as an Associate Editor for the journal Cytometry, a former council member of the International Society for the Advancement of Cytometry, and as the Scientific Chair for CYTO2019. He holds a Ph.D. from the Johns Hopkins Bloomberg School of Public Health and a B.A. from the University of Virginia. Dr. Chattopadhyay is deeply committed to his local community in Mendham, New Jersey, where he founded Sci!, a mentorship program for disadvantaged youth, and Mendham Blue, a group advocating for public interests in government.